Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
BIOCANCELL THERAPEUTICS INC.Listing unverified | Buy | $2.4M | conv 53First in 12mo | SEC | |
BIOCANCELL THERAPEUTICS INC.Listing unverified | Other | $912.4K | SEC | ||
BIOCANCELL THERAPEUTICS INC.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |